Deer­field taps NYU Lan­gone Health as lat­est aca­d­e­m­ic part­ner, ink­ing $130M trans­la­tion­al re­search pact

Deer­field Man­age­ment is ready to add an­oth­er aca­d­e­m­ic re­search cen­ter to its net­work of part­ners, with a com­mit­ment of up to $130 mil­lion over the next 10 years.

NYU Lan­gone Health will work with Deer­field via a new com­pa­ny called Amethyst In­no­va­tions, which will sup­port re­search projects at the med­ical cen­ters in hopes of speed­ing up the ul­ti­mate com­mer­cial­iza­tion of those dis­cov­er­ies.

It joins Co­lum­bia, Har­vard, Duke, Dana-Far­ber and a few oth­ers in sim­i­lar trans­la­tion­al re­search arrange­ments with Deer­field. The New York City-based in­vest­ment firm says such part­ner­ships of­fer an al­ter­na­tive path for re­searchers to take their work for­ward, in­clud­ing both sci­en­tif­ic and op­er­a­tional sup­port as drug can­di­dates ma­te­ri­al­ize and move to­ward the clin­ic. In turn, Deer­field hopes to keep a close re­la­tion­ship with the sci­en­tists be­hind cut­ting-edge in­sights and tech­nolo­gies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER